Results 1 to 10 of about 10,266 (219)
Tofacitinib for Pityriasis Rubra Pilaris: A Case Report
Clinical, Cosmetic and Investigational DermatologyHongyan Tan, Bin Zhang, Xiawei Kang, Lvyao Wang, Xiao Qiu, Xiangyu Hu Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, 400011, People’s Republic of ChinaCorrespondence: Xiangyu Hu, Email 369930758@qq.comPurpose ...
Xiao Qiu
exaly +4 more sources
Indian Journal of Dermatology, 2010 Pityriasis rosea is a frequent papulo-squamous disease and is known for various atypical clinical presentations. We report an adult female patient with a clinical diagnosis of giant pityriasis rosea, which is a rarity in clinical practice.
Zawar Vijay
doaj +4 more sources
Recurrent pityriasis rosea: A case report
Human Vaccines and Immunotherapeutics, 2018 Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either ...
Ang Li, Ping Li, Yanqiong Li, Wenfei Li
exaly +3 more sources
Pityriasis following COVID-19 vaccinations: a systematic review
Dermatology Reports, 2023 In the wake of a global COVID-19 pandemic, where innovations in vaccination technology and the speed of development and distribution have been unprecedented, a wide variety of post-vaccination cutaneous reactions have surfaced.
Laura Duzett +4 more
doaj +3 more sources
Pigment International, 2022 Background: Pityriasis alba (PA) is a common, benign skin disorder occurring predominantly in children and adolescents. It is characterized by the presence of multiple, ill-defined, hypopigmented patches with fine scaling particularly over the face. Aims
Komal A Ramteke +4 more
doaj +1 more source
Tissue immunostaining for factor XIIIa in dermal dendrocytes of pityriasis alba skin lesions [PDF]
Anais Brasileiros de Dermatologia, 2014 BACKGROUND: Pityriasis alba affects 1% of the world population and about 9.9% of the children in Brazil. However, its etiology remains uncertain. OBJECTIVE: The objective of the present study was to evaluate the immunoexpression of factor XIIIa in ...
Francisca Regina Oliveira Carneiro +3 more
doaj +1 more source
JEADV Clinical Practice, 2023 Background Pityriasis rubra pilaris (PRP) is a rare and often severe inflammatory skin disorder with major detriment to patients' quality of life. While past studies have described in detail the morphologic and histopathologic presentations of PRP ...
Rose C. Velasco +3 more
doaj +1 more source
Dermatology Practical & Conceptual, 2016 Background: Pityriasis rosea is a papulosquamous disease. It may occur during pregnancy; in this setting, it has occasionally been associated with adverse outcomes. Purpose: A woman who developed pityriasis rosea at the beginning of her eighth week of
Tiffany Y. Loh, Philip R. Cohen
doaj +1 more source
Pitiríase Versicolor Pityriasis Versicolor
Anais Brasileiros de Dermatologia, 2002 A expressão pitiríase versicolor define uma infecção fúngica superficial caracterizada por alterações na pigmentação cutânea. O distúrbio de pigmentação é devido à colonização do estrato córneo por um fungo dimórfico, lipofílico, encontrado na flora ...
Josenildo Rodrigues de Oliveira +2 more
doaj +1 more source
Pityriasis Rosea Like Drug Rash – A Need to Identify the Disease in Childhood [PDF]
Journal of Clinical and Diagnostic Research, 2014 Pityriasis rosea is a common dermatosis named by Gibert in 1860. It is an acute self limiting papulosquamous disease, probably infective in origin affecting healthy adolescents and young adults.
Maitreyee Panda +4 more
doaj +1 more source